Bonesupport Holding AB (OSTO:BONEX) Cyclically Adjusted PS Ratio: (As of Sep. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:BONEX Bonesupport Holding AB OSTO:BONEX
71 GF Score
Price kr210.20
GF Value kr443.16
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Bonesupport Holding AB Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Bonesupport Holding AB  (OSTO:BONEX) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Bonesupport Holding AB Cyclically Adjusted PS Ratio Related Terms


Bonesupport Holding AB Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Bonesupport Holding AB's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bonesupport Holding AB Cyclically Adjusted PS Ratio Chart

Bonesupport Holding AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 49.97 76.84 28.31

Bonesupport Holding AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 55.33 57.75 28.14 27.41 27.70

OSTO:BONEX vs ISRG, BDX, RMD: Cyclically Adjusted PS Ratio Comparison

For the Medical Instruments & Supplies subindustry, Bonesupport Holding AB's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bonesupport Holding AB Cyclically Adjusted PS Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bonesupport Holding AB's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Bonesupport Holding AB's Cyclically Adjusted PS Ratio falls into.


OSTO:BONEX
71GF Score
Bonesupport Holding AB OSTO:BONEX
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bonesupport Holding AB Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Bonesupport Holding AB's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Bonesupport Holding AB's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=5.327/134.6100*134.6100
=5.327

Current CPI (Jun. 2026) = 134.6100.

Bonesupport Holding AB Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 0.544 101.138 0.724
201612 0.607 102.022 0.801
201703 0.665 102.022 0.877
201706 1.230 102.752 1.611
201709 0.669 103.279 0.872
201712 0.541 103.793 0.702
201803 0.615 103.962 0.796
201806 0.555 104.875 0.712
201809 0.280 105.679 0.357
201812 0.447 105.912 0.568
201903 0.634 105.886 0.806
201906 0.721 106.742 0.909
201909 0.754 107.214 0.947
201912 0.889 107.766 1.110
202003 0.830 106.563 1.048
202006 0.624 107.498 0.781
202009 0.757 107.635 0.947
202012 0.834 108.296 1.037
202103 0.703 108.360 0.873
202106 0.810 108.928 1.001
202109 0.856 110.338 1.044
202112 0.957 112.486 1.145
202203 1.031 114.825 1.209
202206 1.157 118.384 1.316
202209 1.312 122.296 1.444
202212 1.600 126.365 1.704
202303 1.848 127.042 1.958
202306 2.131 129.407 2.217
202309 2.401 130.224 2.482
202312 2.608 131.912 2.661
202403 2.773 132.205 2.823
202406 3.296 132.716 3.343
202409 3.558 132.304 3.620
202412 3.846 132.987 3.893
202503 4.244 132.825 4.301
202506 4.260 133.699 4.289
202509 4.407 133.480 4.444
202512 4.681 133.380 4.724
202603 4.853 133.550 4.892
202606 5.327 134.610 5.327

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Bonesupport Holding AB (OSTO:BONEX) Overvalued in 2026?

Based on GuruFocus' analysis, Bonesupport Holding AB stock appears to be undervalued. The current stock price of kr210.20 is trading 52.6% below its estimated GF Value™ of kr443.16. GuruFocus considers Bonesupport Holding AB to be Significantly Undervalued.

Key valuation signals for OSTO:BONEX:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: kr443.16 vs. price of kr210.20 (52.6% below fair value)
  • GF Score™: 71/100 with 2 warning signs

No single metric tells the full story. See the OSTO:BONEX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Bonesupport Holding AB Business Description

Address Scheelevagen 19, Lund, SWE, SE-223 70
Bonesupport Holding AB is a fast-growing ortho-biologics company that focuses on the treatment of bone disorders. The Company develops and commercializes injectable bio-ceramic bone graft substitutes based on its CERAMENT platform, which remodels to bone and can release pharmaceuticals to promote healing. The products of the company focus on trauma, revision arthroplasty (replacement of joint prostheses), chronic osteomyelitis (bone infection), and foot and ankle surgery. The Group manages and monitors operations in two operating segments: United States and Europe & Rest of the World (EUROW).
71GF Score

Get the complete analysis for OSTO:BONEX

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr210.20
Price
kr443.16
GF Value